Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation TVT 2022

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Presenter: Samir Kapadia

June 10, 2022

Presentation TVT 2022

Cerebral Embolic Protection With Capture: Next Generation Sentinel

Presenter: Axel Linke

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2017

A Critical Appraisal of SENTINEL

Presenter: Axel Linke, Jeffrey J. Popma, Saif Anwaruddin

June 15, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2015

Updates From the US FDAApproved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel K. Kodali

June 05, 2015

Presentation TVT 2015

The European Sentinel Registry

Presenter: Antonio Colombo, Gregg W. Stone, Carlo Di Mario

June 04, 2015

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Advertisement

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Cerebral Embolic Protection With Capture: Next Generation Sentinel

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

A Critical Appraisal of SENTINEL

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

The Sentinel US Pivotal Clinical Trial Design

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Updates From the US FDAApproved Sentinel TAVR Safety and Efficacy Study

The European Sentinel Registry

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content